Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.
NCT ID: NCT00380224
Last Updated: 2007-12-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
120 participants
INTERVENTIONAL
2006-07-31
2007-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bifeprunox, olanzapine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary diagnosis of schizophrenia.
* Total Positive and Negative Symptoms Scale (PANSS) score \<=70 at screening and baseline.
Exclusion Criteria
* History or presence of clinically significant cardiovascular, endocrine, hepatic, renal or other medical disease that might be detrimental to the subject or confound the study.
* History of any suicide attempt within 3 years of day -1 or significant immediate risk of violence or suicidality.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Monitor
Role: STUDY_DIRECTOR
Wyeth is now a wholly owned subsidiary of Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Little Rock, Arkansas, United States
Little Rock, Arkansas, United States
Anaheim, California, United States
Anaheim, California, United States
Anaheim, California, United States
Boynton Beach, California, United States
Costa Mesa, California, United States
Costa Mesa, California, United States
Escondido, California, United States
Garden Grove, California, United States
Glendale, California, United States
Huntington Beach, California, United States
La Mesa, California, United States
National City, California, United States
Oceanside, California, United States
Paramount, California, United States
Rosemead, California, United States
San Diego, California, United States
San Diego, California, United States
San Diego, California, United States
Santa Ana, California, United States
New Britain, Connecticut, United States
New London, Connecticut, United States
DeLand, Florida, United States
Fort Lauderdale, Florida, United States
Jacksonville, Florida, United States
North Miami, Florida, United States
St. Petersburg, Florida, United States
Atlanta, Georgia, United States
Augusta, Georgia, United States
Marietta, Georgia, United States
Coevr d'Alene, Idaho, United States
Chicago, Illinois, United States
Hoffman Estates, Illinois, United States
Joliet, Illinois, United States
Naperville, Illinois, United States
Lake Charles, Louisiana, United States
Gaithersburg, Maryland, United States
Worcester, Massachusetts, United States
Flowood, Mississippi, United States
St Louis, Missouri, United States
St Louis, Missouri, United States
St Louis, Missouri, United States
North Platte, Nebraska, United States
Cherry Hill, New Jersey, United States
Clementon, New Jersey, United States
New York, New York, United States
Rochester, New York, United States
Staten Island, New York, United States
Butner, North Carolina, United States
Chapel Hill, North Carolina, United States
Durham, North Carolina, United States
Morehead City, North Carolina, United States
Fargo, North Dakota, United States
Cleveland, Ohio, United States
Oklahoma City, Oklahoma, United States
Oklahoma City, Oklahoma, United States
Norristown, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Cordova, Tennessee, United States
Memphis, Tennessee, United States
Murfressboro, Tennessee, United States
Nashville, Tennessee, United States
Austin, Texas, United States
DeSoto, Texas, United States
Irving, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3168A1-311
Identifier Type: -
Identifier Source: org_study_id